V1b and CRHR1 receptor heterodimerization mediates synergistic biological actions of vasopressin and CRH.
about
Role of mecp2 in experience-dependent epigenetic programmingThe specific monomer/dimer equilibrium of the corticotropin-releasing factor receptor type 1 is established in the endoplasmic reticulumOrexin-corticotropin-releasing factor receptor heteromers in the ventral tegmental area as targets for cocaineCRHR1 genotypes, neural circuits and the diathesis for anxiety and depression.Family-based study of AVPR1B association and interaction with stressful life events on depression and anxiety in suicide attempts.Pharmacological characterization of FE 201874, the first selective high affinity rat V1A vasopressin receptor agonist.Vasopressin V1a and V1b receptor modulators: a patent review (2012 - 2014).Corticotropin-Releasing Factor Receptors and Their Interacting Proteins: Functional Consequences.Endocrinology and the brain: corticotropin-releasing hormone signaling.Actin cytoskeleton-dependent regulation of corticotropin-releasing factor receptor heteromers.Social Context, Stress, Neuropsychiatric Disorders, and the Vasopressin 1b Receptor.The frontal cortex as a network hub controlling mood and cognition: Probing its neurochemical substrates for improved therapy of psychiatric and neurological disorders.Altered stress responsiveness and hypothalamic-pituitary-adrenal axis function in male rat offspring of socially isolated parents.Acute and chronic hyperglycemic effects of vasopressin in normal rats: involvement of V1A receptors.Gender-specific co-activation of arginine vasopressin and the hypothalamic-pituitary-adrenal axis during stress.
P2860
Q27025146-94B80FDE-A041-43A6-95BA-ADB247C1A362Q34107232-AFB6719B-D2DF-4893-AF3A-99D628761EFCQ35547856-34965176-DD8B-40EF-9162-3E16380B72EBQ36874776-7306CDFF-FD0B-4652-A379-B3BA5D741A33Q36927751-0711A6BE-E788-4176-BC35-B3423BC78323Q37327368-F7CC80A7-353B-4BF5-8EB1-9124235D6E2BQ38380027-11B1AE4B-BE4C-44EA-84F9-245A24CAEBBAQ38950447-796958D6-59D0-42C6-B4A1-15A1EB4CEFE7Q39436094-87C44E7B-4033-4526-9FA1-53F31448F0BAQ43491697-B2F42605-DAE1-47B1-9BDD-AD2DCA3CC61DQ46949421-5BEA0B09-7263-4C58-A908-48D5C8A8BF72Q47382890-05F1D8A4-C7D2-4B9B-AAB5-182E8149A34CQ47895901-88342EF9-D5BB-47C3-815F-32F4598196E6Q48132369-85005972-E04C-4451-9965-0BBBBCFF7998Q48556962-300FFDD5-C4EF-48A7-9BCB-E53A32C37823
P2860
V1b and CRHR1 receptor heterodimerization mediates synergistic biological actions of vasopressin and CRH.
description
2012 nî lūn-bûn
@nan
2012 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
V1b and CRHR1 receptor heterod ...... ctions of vasopressin and CRH.
@ast
V1b and CRHR1 receptor heterod ...... ctions of vasopressin and CRH.
@en
type
label
V1b and CRHR1 receptor heterod ...... ctions of vasopressin and CRH.
@ast
V1b and CRHR1 receptor heterod ...... ctions of vasopressin and CRH.
@en
prefLabel
V1b and CRHR1 receptor heterod ...... ctions of vasopressin and CRH.
@ast
V1b and CRHR1 receptor heterod ...... ctions of vasopressin and CRH.
@en
P2093
P2860
P356
P1476
V1b and CRHR1 receptor heterod ...... ctions of vasopressin and CRH.
@en
P2093
Brigitte Murat
Dominic Devost
Gilles Guillon
Hans H Zingg
Julie Mion
Maithé Corbani
Miriam Andrés
Véra Boulay
P2860
P304
P356
10.1210/ME.2011-1202
P577
2012-02-02T00:00:00Z